# Quantum Genomics SA

Organization · id `cardio:org-quantum-genomics-sa` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Quantum+Genomics+SA>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Quantum Genomics SA
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins (`cardio:ct-nct03198793`)
- Sponsors: Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (`cardio:ct-nct03715998`)
- Sponsors: Firibastat in Treatment-resistant Hypertension (`cardio:ct-nct04277884`)
- Sponsors: Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH) (`cardio:ct-nct04857840`)

## Provenance

Content hash: 080df27e6cc30459993653f194cae80110548a27b1a99f505f6fa280d6d37c38
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
